Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 25(20): 2839-49, 2006 May 11.
Article in English | MEDLINE | ID: mdl-16407843

ABSTRACT

This study provides evidence for the importance of p21(CDKN1A) for the repair of replication-mediated DNA double-strand breaks (DSBs) induced by topoisomerase I. We report that defects of p21(CDKN1A) and p53 enhance camptothecin-induced histone H2AX phosphorylation (gammaH2AX), a marker for DNA DSBs. In human colon carcinoma HCT116 cells with wild-type (wt) p53, gammaH2AX reverses after camptothecin removal. By contrast, gammaH2AX increases after camptothecin removal in HCT116 cells deficient for p53 (p53-/-) or p21(CDKN1A) (p21-/-) as the cells reach the late-S and G2 phases. Since p21-/- cells exhibit similar S-phase arrest as wt cells in response to camptothecin and aphidicolin does not abrogate the enhanced gammaH2AX formation in p21-/- cells, we conclude that enhanced gammaH2AX formation in p21-/- cells is not due to re-replication. The cell cycle checkpoint abrogator and Chk1/Chk2 inhibitor 7-hydroxystaurosporine (UCN-01) also increases camptothecin-induced gammaH2AX formation and inhibits camptothecin-induced p21(CDKN1A) upregulation in HCT116 wt cells. TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling) assays demonstrate that gammaH2AX formation in late S and G2 cells following CPT treatment corresponds to DNA breaks. However, these breaks are not related to apoptotic DNA fragmentation. We propose that p21(CDKN1A) prevents the collapse of replication forks damaged by stabilized topoisomerase I cleavage complexes.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/physiology , DNA Repair/physiology , DNA Replication , DNA Topoisomerases, Type I/pharmacology , DNA/metabolism , Protein Kinase Inhibitors/pharmacology , Staurosporine/analogs & derivatives , Aphidicolin/pharmacology , Apoptosis/drug effects , Chromosome Breakage , Colonic Neoplasms/drug therapy , Colonic Neoplasms/metabolism , Cyclin-Dependent Kinase Inhibitor p21/antagonists & inhibitors , DNA/genetics , DNA Damage/drug effects , HCT116 Cells , Histones/metabolism , Humans , In Situ Nick-End Labeling , Phosphorylation/drug effects , Protein Kinase C/antagonists & inhibitors , S Phase/drug effects , Staurosporine/pharmacology , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/physiology
2.
Science ; 281(5379): 1005-9, 1998 Aug 14.
Article in English | MEDLINE | ID: mdl-9703500

ABSTRACT

The timing and localization of DNA replication initiation in mammalian cells are heritable traits, but it is not known whether initiation requires specific DNA sequences. A site-specific recombination strategy was used to show that DNA sequences previously identified as replication initiation sites could initiate replication when transferred to new chromosomal locations. An 8-kilobase DNA sequence encompassing the origin of DNA replication in the human beta-globin locus initiated replication in the simian genome. Specific deletions within the globin origin did not initiate replication in these chromosomal sites. These data suggest that initiation of DNA replication in mammalian cells requires specific sequence information and extend the replicon hypothesis to higher eukaryotes.


Subject(s)
DNA Replication , Globins/genetics , Replication Origin , Viral Proteins , Animals , Cell Line , Chlorocebus aethiops , DNA/genetics , DNA Nucleotidyltransferases/metabolism , Gene Targeting , Humans , Integrases/metabolism , Polymerase Chain Reaction , S Phase , Sequence Deletion
3.
Curr Biol ; 8(3): 145-55, 1998 Jan 29.
Article in English | MEDLINE | ID: mdl-9443911

ABSTRACT

BACKGROUND: Embryonic stem (ES) cells can contribute precursors to all adult cell lineages. Consequently, damage to ES cell genomes may cause serious developmental malfunctions. In somatic cells, cell-cycle checkpoints limit DNA damage by preventing DNA replication under conditions that may produce chromosomal aberrations. The tumor suppressor p53 is involved in such checkpoint controls and is also required to avoid a high rate of embryonic malformations. We characterized the cell-cycle and DNA-damage responses of ES cells to elucidate the mechanisms that prevent accumulation or transmission of damaged genomes during development. RESULTS: ES cells derived from wild-type mice did not undergo cell-cycle arrest in response to DNA damage or nucleotide depletion, although they synthesized abundant quantities of p53. The p53 protein in ES cells was cytoplasmic and translocated inefficiently to the nucleus upon nucleotide depletion. Expression of high levels of active p53 from an adenovirus vector could not trigger cell cycle arrest. Instead, ES cells that sustained DNA damage underwent p53-independent apoptosis. The antimetabolite-induced p53-dependent arrest response was restored in ES cells upon differentiation. CONCLUSIONS: Cell-cycle regulatory pathways in early embryos differ significantly from those in differentiated somatic cells. In undifferentiated ES cells, p53 checkpoint pathways are compromised by factors that affect the nuclear localization of p53 and by the loss of downstream factors that are necessary to induce cell-cycle arrest. A p53-independent programmed cell death pathway is effectively employed to prevent cells with damaged genomes from contributing to the developing organism. The p53-mediated checkpoint controls become important when differentiation occurs.


Subject(s)
Apoptosis , Cell Cycle/physiology , DNA Damage , Embryo, Mammalian/cytology , Stem Cells/metabolism , Tumor Suppressor Protein p53/physiology , Antimetabolites/pharmacology , Aspartic Acid/analogs & derivatives , Aspartic Acid/pharmacology , Cell Differentiation/drug effects , Cell Nucleus/metabolism , Doxorubicin/pharmacology , Gamma Rays , Humans , Phosphonoacetic Acid/analogs & derivatives , Phosphonoacetic Acid/pharmacology , Stem Cells/drug effects , Stem Cells/radiation effects , Transfection , Tretinoin
4.
Mol Cell Biol ; 17(2): 857-61, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9001240

ABSTRACT

Site-specific recombination provides a powerful tool for studying gene function at predetermined chromosomal sites. Here we describe the use of a blasticidin resistance system to select for recombination in mammalian cells using the yeast enzyme FLP. The vector is designed so that site-specific recombination reconstructs the antibiotic resistance marker within the sequences flanked by the FLP target sites. This approach allows the detection of DNA excised by FLP-mediated recombination and facilitates the recovery of recombination products that would not be detected by available screening strategies. We used this system to show that the molecules excised by intrachromosomal recombination between tandem FLP recombinase target sites do not reintegrate into the host genome at detectable frequencies. We further applied the direct selection approach to recover a rare FLP-mediated recombination event displaying the characteristics of an unequal sister chromatid exchange between FLP target sites. Implications of this approach for the generation of duplications to assess their effect on gene dosage and chromosome stability are discussed.


Subject(s)
DNA Nucleotidyltransferases , Genetic Vectors/genetics , Recombination, Genetic , Sister Chromatid Exchange , Animals , Cell Line , DNA Nucleotidyltransferases/genetics , Drug Resistance, Microbial/genetics , Gene Targeting , Genetic Markers , Haplorhini , Multigene Family , Nucleosides/pharmacology
5.
Methods ; 13(3): 281-92, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9441854

ABSTRACT

Replication fork polarity methods measure the direction of DNA synthesis by taking advantage of the asymmetric nature of DNA replication. One procedure that has been used on a variety of cell lines from different metazoans relies on the isolation of newly replicated DNA strands in the presence of the protein synthesis inhibitor emetine. Since Okazaki fragments are not synthesized under such conditions, DNA strands produced during continuous exposure to emetine consist mainly of leading strands. In the protocol described, leading strands isolated from emetine treated cells are detected with single-stranded probes representing each strand of the DNA duplex in the region of interest. Hybridization of leading strands to one strand of a cloned genomic template identifies the direction of replication fork movement. If initiation of DNA synthesis occurs from a preferred site, leading strands should diverge from the corresponding initiation region. The leading strand method is particularly useful for mapping initiation in chromosomal loci that do not replicate immediately on entry into S phase and in mapping the replication fork patterns in which candidate initiation regions have not been identified. Cautious interpretation of the results is needed because the method relies heavily on quantitative hybridization. Leading strand data can be difficult to interpret when the genomic targets are very close to initiation regions and when the targets vary in their hybridization efficiency or in the efficiency of incorporation of nucleotide analogs. The experimental details of the method are reviewed, controls to avoid common pitfalls are suggested, protocols to facilitate the accurate interpretation of the results are provided.


Subject(s)
DNA Replication , Gene Expression , Nucleotide Mapping/methods , Animals , Blotting, Southern , Centrifugation, Density Gradient , Humans , Nucleic Acid Hybridization
6.
Science ; 270(5237): 815-9, 1995 Nov 03.
Article in English | MEDLINE | ID: mdl-7481774

ABSTRACT

The human beta-globin locus control region (LCR) controls the transcription, chromatin structure, and replication timing of the entire locus. DNA replication was found to initiate in a transcription-independent manner within a region located 50 kilobases downstream of the LCR in human, mouse, and chicken cells containing the entire human beta-globin locus. However, DNA replication did not initiate within a deletion mutant locus lacking the sequences that encompass the LCR. This mutant locus replicated in the 3' to 5' direction. Thus, interactions between distantly separated sequences can be required for replication initiation, and factors mediating this interaction appear to be conserved in evolution.


Subject(s)
DNA Replication , Globins/genetics , Regulatory Sequences, Nucleic Acid , Animals , Base Sequence , Biological Evolution , Cell Line , Chickens , Humans , Hybrid Cells , Mice , Molecular Sequence Data , Sequence Deletion , Tumor Cells, Cultured
7.
Virology ; 189(2): 493-9, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1322584

ABSTRACT

Carcinogen-induced expression of the integrated viral genome was examined on SV40-transformed Chinese hamster cells. Carcinogen treatment markedly increased the transcription rate and the steady state mRNA level of both early and late viral transcripts. Carcinogen-induced transcription was mediated by RNA polymerase II. The increase in viral gene expression was also detected at the protein level, although at a reduced amplitude. Enhanced transcription was apparent as early as 12 hr postexposure and was considerably elevated after 24-36 hr. The increased gene expression depended on the existence of a functional replication machinery, as indicated by two lines of evidence. First, a cell line that harbors origin-deleted SV40 failed to respond to carcinogen treatment by increasing transcription and expression of T antigen. Furthermore, carcinogen-induced overtranscription was inhibited by aphidicolin, an inhibitor of DNA polymerase alpha. The involvement of the replication apparatus in the enhanced expression points to mechanistic similarities between the carcinogen-induced viral gene expression in the drug-treated semipermissive cells and the SV40 lytic pathway under permissive conditions. It is therefore suggested that cellular permissivity to viral development is enhanced following exposure to carcinogens. The implications of these findings for the nature of cellular permissivity to viral infection and the synergistic effects of carcinogens and tumor viruses are discussed.


Subject(s)
Carcinogens/pharmacology , Gene Expression Regulation, Viral/drug effects , Simian virus 40/genetics , Amanitins/pharmacology , Animals , Antigens, Polyomavirus Transforming/genetics , Aphidicolin/pharmacology , Cell Nucleus/metabolism , Cricetinae , Cricetulus , RNA, Messenger/genetics , RNA, Viral/genetics , Transcription, Genetic/drug effects , Virus Replication/drug effects
8.
Mutat Res ; 276(3): 339-44, 1992 May.
Article in English | MEDLINE | ID: mdl-1374526

ABSTRACT

Exposure to chemical carcinogens provides a means for the enhancement of the frequency of gene amplification and for the facilitation of research into its mechanism(s). Using carcinogen-induced SV40 amplification as a model system it was shown that amplification of the viral sequences occurs via a replication-dependent mode. This process involves overactivation of the origin region and the generation of inverted repeats. Carcinogen-induced enhancement of gene amplification is triggered by cellular factors that could act in trans. An in vitro amplification system, based on extracts from carcinogen-treated cells and SV40 template sequences, was used to further characterize the amplification intermediates. The major products of overreplication in this system consist of sequences derived from the origin region. Our studies suggest that the ability to overreplicate the origin region in vitro derives from the combined action of carcinogen-induced factors that trigger overinitiation, with the inherent inability of Chinese hamster cell extracts to fully replicate large plasmid templates. The newly replicated sequences are not associated with the parental molecule and contain hairpin or stem and loop structures. Based on these findings we propose a novel replicative mechanism for DNA amplification that allows the de novo formation of hairpin structures. According to this model, an obstruction of the replication fork may cause an overturning of the DNA polymerase, followed by a template switch that leads to the use of the newly replicated strand as a template. This mode of replication results in the generation of hairpin structures which can function as precursors for the duplicated inverted repeats which are commonly observed in amplified genomes. This model is supported by our in vitro and in vivo studies. The relevance of this model for the amplification of cellular sequences is discussed.


Subject(s)
Carcinogens/pharmacology , Gene Amplification/genetics , Gene Expression Regulation, Neoplastic/drug effects , Simian virus 40/genetics , Animals , Antigens, Polyomavirus Transforming/genetics , Cell Line, Transformed , Cricetinae , Cricetulus , Humans , Models, Genetic , Multigene Family/genetics , Nucleic Acid Conformation , Plasmids/genetics , Repetitive Sequences, Nucleic Acid/genetics
9.
Mol Gen Genet ; 211(1): 88-94, 1988 Jan.
Article in English | MEDLINE | ID: mdl-3278196

ABSTRACT

Carcinogen-induced amplification at the CupI locus, coding for a metallothionein protein, was studied in the yeast Saccharomyces cerevisiae. Exposure of cells from three different haploid strains, 4939, DBY746 and 320, to chemical carcinogens such as N-methyl-N'-nitro-N-nitroso-guanidine (MNNG), ethylmethanesulfonate (EMS) and 4-nitroquinoline-N-oxide (4NQO) enhanced the frequency of copper-resistant colonies up to several hundred fold. Copper-resistant clones obtained from strains DBY746 and 320, which contain more than one copy of the CupI locus, displayed a four- to eightfold amplification of the CupI sequences. In these clones the amplified CupI sequences were organized in a tandem array. Carcinogen treatment of strain 4939 in which only one copy of the CupI gene is present produced resistant colonies without CupI amplification. The possible use of the yeast system to study gene duplication and amplification is discussed.


Subject(s)
Carcinogens/toxicity , Copper/toxicity , Gene Amplification , Metallothionein/genetics , Saccharomyces cerevisiae/genetics , Chromosome Mapping , Drug Resistance , Gene Amplification/drug effects , Genes, Fungal , Mutation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...